Xinning Wang
12Patents
4h-index
15Co-inventors
53Inventor score
Filing activity: Feb 18, 2014 → Aug 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9889199B2 | PSMA ligands and uses thereof | Human Necessities | 14 | Active |
| US10363313B2 | PSMA ligands and uses thereof | Human Necessities | 10 | Active |
| US10207005B2 | Photodynamic therapy composition | Human Necessities | 8 | Active |
| US10709794B2 | Photodynamic therapy composition | Human Necessities | 6 | Active |
| US10434194B2 | PSMA targeted nanobubbles for diagnostic and therapeutic applications | Chemistry; Metallurgy | 4 | Active |
| US9713649B2 | PSMA-targeting imaging agents | Human Necessities | 2 | Active |
| US11202836B2 | PSMA targeted conjugate compounds and uses thereof | Human Necessities | 1 | Active |
| US10918741B2 | PSMA-targeting imaging agents | Human Necessities | 1 | Active |
| US12133901B2 | PSMA ligand targeted compounds and uses thereof | Performing Operations; Transporting | 0 | Active |
| US12144863B2 | PSMA targeted conjugate compounds and uses thereof | Human Necessities | 0 | Active |
| US11998620B2 | PSMA targeted compounds and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11999957B2 | Method for enhancing vanillin resistance of Saccharomyces cerevisiae by knocking out SNG1 gene | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.